moderna fda - Search News

Moderna looks outside US for growth

· 2d · on MSN

Moderna looks outside US for growth after FDA's flu shot refusal

By Mariam Sunny and Michael Erman Feb 13 (Reuters) - Moderna said it is looking for growth overseas after the U.S. FDA refused to review its experimental flu shot and the country's top health officials have deprioritized vaccination.

Continue reading

What the FDA's rejection of Moderna's flu shot means for the future of vaccines

FDA refuses to consider Moderna flu shot in move experts claim is part of ‘anti-vaccine agenda’

2don MSN

Moderna blames FDA for threatening US leadership in medicine

Moderna Inc. lashed out at the US Food and Drug Administration for making it harder for companies to create new medicines, ...

2d

Wall Street eyes Moderna earnings after FDA rebuff

Moderna will report its fourth-quarter 2025 earnings this morning in an investor call that’s taken on even more interest in ...

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...

4don MSN

Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results